Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
Public ClinicalTrials.gov record NCT02283762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate if Riociguat is effective in the treatment of systemic sclerosis
Study identification
- NCT ID
- NCT02283762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 15, 2015 (Actual)
- Primary completion
- Dec 15, 2017 (Actual)
- Completion
- Mar 28, 2019 (Actual)
- Last update posted
- Feb 5, 2020
2015 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Scottsdale | Scottsdale | Arizona | 85259-5404 | — |
| UCLA David Geffen School of Medicine | Los Angeles | California | 90095-1670 | — |
| Stanford University School of Medicine | Palo Alto | California | 94304 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Rutgers Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Medical University of South Carolina Medical Center | Charleston | South Carolina | 29425 | — |
| Memorial Hermann-Texas Medical Center | Houston | Texas | 77030 | — |
| University of Utah Health Care | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02283762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2020 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02283762 live on ClinicalTrials.gov.